Skip to content
A new biotech company says they can reverse the aging process in living cells by “flipping” DNA markers, helping us stay healthier longer, according […]
Biotech firm chasing ‘fountain of rejuvenation’ Read More »
A new, cross-sectional study on the prevalence of post-acute sequelae of SARS CoV-2 infection shows that women are almost twice as likely to experience
Women are twice as likely to have long COVID, says new research Read More »
Engaging with women veterans is critically important, said speakers at the Biotechnology Innovation Organization’s (BIO) third annual Veterans Day Coffee Chat, which took place
How to advocate for women veterans – and why it matters Read More »
Climate change has already had a massive impact on crops and agriculture, but the health care sector is bracing itself for an onslaught of
Climate change exacerbates infectious diseases, studies find Read More »
BIO member Pfizer Inc.’s antiviral drug Paxlovid, which has already been shown to reduce the risk of hospitalization and death from COVID-19, can also
Paxlovid reduces the risk of long COVID, says study Read More »
Provisions in the Inflation Reduction Act (IRA) make it easier for people covered by Medicare Part D to pay for medicine, but continued government
CMS must flesh out plan to ease out-of-pocket drug costs, report says Read More »
Johnson & Johnson announced Wednesday it is buying the world leader in breakthrough heart, lung, and kidney support technologies, Abiomed, “for an upfront payment
Johnson & Johnson strengthens MedTech business, acquires Abiomed Read More »
The WTO IP waiver for COVID-19 vaccines was never about vaccine distribution—it was a political calculation, according to Hans Sauer, Deputy General Counsel for
WTO IP waiver was always political: BIO’s patent lawyer breaks it down Read More »
Using synthetic biology to make consumer products more sustainable has proven to be a winning formula for Amyris, a BIO member company that announced expansion in
Making sustainable products with synbio is a winning formula for Amyris Read More »
A paper from the Innovation and Value Initiative (IVI) and Sick Cells, a national sickle cell advocacy organization, demonstrates how traditional approaches used to
Value assessments can exacerbate health inequity, report finds Read More »
